Current Real-World Status of Oral Anticoagulant Management in Japanese Patients.

IF 3.1 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Circulation Journal Pub Date : 2025-01-24 Epub Date: 2024-11-15 DOI:10.1253/circj.CJ-24-0827
Tomoya Hara, Masataka Sata
{"title":"Current Real-World Status of Oral Anticoagulant Management in Japanese Patients.","authors":"Tomoya Hara, Masataka Sata","doi":"10.1253/circj.CJ-24-0827","DOIUrl":null,"url":null,"abstract":"<p><p>Anticoagulant therapy is a drug therapy that inhibits the formation of blood clots. Although anticoagulants are effective in preventing thromboembolism, they also carry the risk of bleeding, so they must be managed carefully, taking both efficacy and safety into account. Evidence regarding the effectiveness and safety of each anticoagulant has already accumulated through many large clinical trials and post-marketing surveillance. However, when making decisions in clinical practice, it is necessary to always take into consideration differences in patient populations between clinical trials and actual clinical practice, as well as differences in historical background. (For example, there are differences in antiplatelet drugs and coronary artery interventions that were mainly used in each era.) In this review we discuss the effectiveness and safety of currently used anticoagulants, focusing on different patient backgrounds and points to keep in mind regarding their proper use, based on the latest reports in Asian populations, especially Japanese people, over the past 1-2 years.</p>","PeriodicalId":50691,"journal":{"name":"Circulation Journal","volume":" ","pages":"150-152"},"PeriodicalIF":3.1000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1253/circj.CJ-24-0827","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Anticoagulant therapy is a drug therapy that inhibits the formation of blood clots. Although anticoagulants are effective in preventing thromboembolism, they also carry the risk of bleeding, so they must be managed carefully, taking both efficacy and safety into account. Evidence regarding the effectiveness and safety of each anticoagulant has already accumulated through many large clinical trials and post-marketing surveillance. However, when making decisions in clinical practice, it is necessary to always take into consideration differences in patient populations between clinical trials and actual clinical practice, as well as differences in historical background. (For example, there are differences in antiplatelet drugs and coronary artery interventions that were mainly used in each era.) In this review we discuss the effectiveness and safety of currently used anticoagulants, focusing on different patient backgrounds and points to keep in mind regarding their proper use, based on the latest reports in Asian populations, especially Japanese people, over the past 1-2 years.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
日本患者口服抗凝剂管理的实际现状。
抗凝疗法是一种抑制血栓形成的药物疗法。虽然抗凝剂能有效预防血栓栓塞,但也有出血的风险,因此必须在考虑疗效和安全性的基础上谨慎使用。通过许多大型临床试验和上市后监测,已经积累了有关每种抗凝剂有效性和安全性的证据。然而,在临床实践中做出决定时,有必要始终考虑到临床试验与实际临床实践之间患者群体的差异以及历史背景的差异。(例如,每个时代主要使用的抗血小板药物和冠状动脉介入治疗存在差异)。在本综述中,我们将根据过去 1-2 年在亚洲人群(尤其是日本人)中的最新报告,讨论目前使用的抗凝药物的有效性和安全性,重点关注不同患者背景以及正确使用抗凝药物的注意事项。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Circulation Journal
Circulation Journal 医学-心血管系统
CiteScore
5.80
自引率
12.10%
发文量
471
审稿时长
1.6 months
期刊介绍: Circulation publishes original research manuscripts, review articles, and other content related to cardiovascular health and disease, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in basic and translational research.
期刊最新文献
Sex Differences in Post-Noncardiac Surgery Risks Assessed Using the Revised Cardiac Risk Index - A Nationwide Retrospective Cohort Study. Sinus Sequestration as a Complication of Transcatheter Aortic Valve-in-Transcatheter Aortic Valve for Valve Embolization. JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias. Quality Metrics for Heart Failure - A Guideline-Driven Indicator Development Using a Modified Delphi Process and Its Applicability to Contemporary Japanese Practice. Circulation Journal Awards for the Year 2024.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1